Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hexahydro-1,4-diazepine | HCID 68163 | — |
| Reactant | 1,8-Diazabicyclo(5.4.0)undec-7-ene | HCID 81184 | — |
| Reactant | 2-chloro-1-(2-ethoxyethyl)-1H-benzimidazole | HCID 10489356 | — |
| Solvent | Pyridine | HCID 1049 | — |
| Product | Emedastine EP Impurity E | HCID 9984168 | — |
| Product | Ammonia methanol | HCID 21705897 | 2% |
Reaction Steps
Alternately, combine 2-chloro-1-(2-ethoxyethyl)-1H-benzimidazole (15.56 g, 69.3 mmol) and [1,4]diazepane (13.89 g, 138.7 mmol), 1,8-diazabicyclo[5.4.0]undec-7-ene (12.34 mL, 83.1 minol), and pyridine (200 mL). Heat to reflux. After 18 hours, cool to ambient temperature and evaporate in vacuo to give a residue. Partition the residue between aqueous 1 M sodium hydroxide solution and dichloromethane. Separate the layers and extract the aqueous layer two times with dichloromethane. Combine the organic layers, extract with aqueous 1 M sodium hydroxide solution, water, and then brine. Dry the organic layer over Na2SO4, filter, and evaporate in vacuo to give a residue. Chromatograph the residue on silica gel eluting with 2% concentrated aqueous ammonia/methanol to give the title compound: Rf=0.26 (silica gel, 2% concentrated aqueous ammonia/methanol).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06423704B1 |
|---|
| Source dataset | uspto-grants-2002_07 |
|---|
| ORD ID | ord-ba2bfc5b9f6c485f87664ee12cd966ad |
|---|
| Source note | uspto-grants-2002_07 |
|---|